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Sertraline (SERT) is a clinically effective Selective Serotonin Reuptake Inhibitor (SSRI)
known to increase and stabilize serotonin levels. This neurotransmitter plays an important
role in adolescent brain development in both rodents and humans, and its dysregulation
has been correlated with deficits in behavior and emotional regulation. Since prenatal
stress may disturb serotoninergic homeostasis, the aim of this study was to examine
the long-lasting effects of exposure to SERT throughout adolescence on behavioral and
physiological developmental parameters in prenatally stressed Wistar rats. SERT was
administered (5 mg/kg/day p.o.) from the age of 1–3 months to half of the progeny, of
both sexes, of gestating dams stressed by use of a restraint (PS) or not stressed. Our
data reveal that long-term SERT treatment slightly reduced weight gain in both sexes, but
reversed the developmental disturbed “catch-up” growth found in PS females. Neither
prenatal stress nor SERT treatment induced remarkable alterations in behavior and had no
effects on mean startle reflex values. However, a sex-dependent effects of PS was found:
in males the PS paradigm slightly increased anxiety-like behavior in the open field, while
in females, it impaired startle habituation. In both cases, SERT treatment reversed the
phenomena. Additionally, the PS animals exhibited a disturbed leukocyte profile in both
sexes, which was reversed by SERT. The present findings are evidence that continuous
SERT administration from adolescence through adulthood is safe in rodents and lessens
the impact of prenatal stress in rats.
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INTRODUCTION
Sertraline (SERT) is a clinically effective Selective Sero-
tonin Reuptake Inhibitor (SSRI) that increases serotonin
(5-hydroxytryptamine, 5-HT) levels in the brain (Koe et al., 1983;
Byerley et al., 1987; Manfridi et al., 1992) and hence plays an
important role in stabilizing nervous activity.
Even though there are many children and adolescents with
psychiatric disorders (Emslie and Mayes, 2001), decisions regard-
ing the use of antidepressants in young people (such as the
SSRIs) are still largely based on data from adults (Manfridi
et al., 1992; de Jong et al., 2006). Efficacy measurements
in humans recommend SSRIs as the initial medication of
choice for young individuals in depression and for improv-
ing obsessive-compulsive disorder (OCD; Doogan and Cail-
lard, 1988; Alderman et al., 1998; Emslie and Mayes, 2001;
Moreno et al., 2006). SERT seems to be well tolerated in both
children and adolescents, with adverse effects similar to those
previously reported by adult patients (Alderman et al., 1998;
Cook et al., 2001; Skaer et al., 2009). However, side effects
with impact on later development have not yet been fully
elucidated.
The serotoninergic system is highly complex, as evidenced
by the great diversity of subtypes of receptors on which this
neurotransmitter acts (at least 14 different subtypes) and the
variety of functions regulated by each receptor subtype (O’Leary
et al., 2013). 5-HT presynaptic receptors are located in the dorsal
raphe nuclei (DRN) and postsynaptic 5-HT receptors (5-HTR)
are largely present in the limbic system (Newport et al., 2001;
Hensler, 2003; Leventopoulos et al., 2009). Thus, disturbing
serotoninergic homeostasis during its development may result
in a changed framework of brain connections and permanent
alterations may be induced in adult behavior (Morley-Fletcher
et al., 2003; Whitaker-Azmitia, 2005; Ansorge et al., 2008).
It is known that prenatal stress disturbs serotoninergic
metabolism (Peters, 1986; Hayashi et al., 1998; Maccari and
Morley-Fletcher, 2007) and is responsible for several psychiatric
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disorders and negative affective states later in life, such as anx-
iety and depression (Green et al., 2011). These disorders have
previously been related to low 5-HT levels (Koe, 1990; Graeff,
2004; Ansorge et al., 2008), and more recently such low levels
have been implicated in developmental perturbations, both in
laboratory animals (Kay et al., 1998; Coe and Lubach, 2005; Götz
and Stefanski, 2007) and in humans (Cottrell and Ozanne, 2008;
O’Connor et al., 2013). This early type of stress can affect the loss
of synapses and dendritic arborization, which normally occurs
from puberty to adulthood (Barros et al., 2006; Zhang et al.,
2013), and induces a decrease in the levels of 5-HT in the brains
of young individuals (Hayashi et al., 1998).
It has also been suggested that anxiety and depression-like
effects could be counteracted by treating prenatally stressed off-
spring with antidepressants that affect the serotonin system, such
as SSRIs (Matar et al., 2006; Van den Hove et al., 2005). Never-
theless, few studies have addressed the impact of these treatments
during the developmental stage of adolescence.
The acoustic startle reflex (ASR) and its habituation, both con-
sidered good tools for the investigation of emotional status and
the brain mechanisms involved in behavioral plasticity, are often
used in pharmacological animal models (Davis, 1980; Dulawa
and Geyer, 2000; Quednow et al., 2004; Jensen et al., 2007). In
view of the involvement of this (5-HT) transmitter system in the
descending pathways modulating the startle reflex (Geyer et al.,
2001; Quednow et al., 2004), it seem seems quite clear that its
manipulation would alter the startle response.
Thus, to evaluate the long-lasting effects induced by both early
stress and exposure to antidepressants during youth, our main
goal was to determine the neurobiological changes in previously
stressed rats subjected to SERT treatment. Considering during
this developmental period, in humans, antidepressant treatments
could last for years (O’Leary et al., 2013), SERT was given from
the beginning of adolescence of the animals until the end of the
experiments, when they were fully grown. Along the experiment,
physiological (body weight gain, appetite, thirst, and immuno-
logical function) and behavioral measurements (anxiety-related
behaviors using the open field and the ASR paradigm) were taken.
To best of our knowledge, few data on the long-term effects
of pharmacological therapy with SERT during adolescence in
normal (control) or previously disturbed (PS) subjects of both
sexes are currently available. Thus, we hope present findings
help to further our understanding of the long-term effects of
antidepressants during this critical window of brain development.
MATERIALS AND METHODS
ANIMALS
Virgin female Wistar rats CLS:WI(HAN) (n = 12) weighting 250 g
were obtained from outbred rats from our own animal facility at
the University of Salamanca. Vaginal smears were collected daily
for 8 days before mating to determine the stage of the estrus
cycle and the day of conception. On the day of proestrus, sexually
experienced male Wistar rats were introduced for mating. The day
the spermatozoa were found in the smear was designated as day 1
of pregnancy.
The animals were housed randomly and maintained under
a normal 12/12 h light/dark cycle (lights on at 08:00 h) in
a temperature- and humidity-controlled environment. The rats
were given ad libitum access to food and water along the study
period. The experiments were conducted in compliance with the
guidelines for the use and care of laboratory animals of the Euro-
pean Communities Council Directive (2010/63/EU), the current
Spanish legislation (RD 1201/05), and with those established by
the Institutional Bioethics Committee. All efforts were made to
minimize the number of animals used.
EXPOSURE TO PRENATAL STRESS
Pregnant female rats were randomly assigned to the stress or
control groups (n = 6 per group) and housed individually in
plastic breeding cages. Stress consisted on placing the females
in the third trimester of gestation (days 15–21) on transparent
cylinder restrainers (7 cm diameter, 19 cm long); under a bright
light directed onto the surface of the restrainer for 45 min three
times a day (at 9 am, 12 pm, and 4 pm) (adapted from Lemaire
et al., 2000). Control mothers were only subjected to routine
changes (handling them the less as possible), as were the stressed
females. All stress and control mothers delivered normally and
only offspring from litters containing 9–13 pups were used in
the experiments. Offspring were weighted at birth and weaned at
21 days of age, after which they were separated into group cages
housing four animals of the same sex and treatment. Then, the
pups were tail-marked and body weights were recorded weekly.
Thirty days after birth, pups from one of the two groups,
Control vs. PS, depending on the previous treatment, were sub-
divided, to receive either chronic treatment with SERT (Control-
SERT and PS-SERT) or not (Control, PS). This resulted in equal
number of animals in each condition (n = 9–11 per sex and
group). To avoid the effect of the dams, care was taken so that
groups included no more than two pups from the same litter,
in agreement with the protocols and results of previous authors
(Bowman et al., 2004; Estanislau and Morato, 2006; Van den
Hove et al., 2014). Additionally, a cursory analysis revealed no
differences in litter sizes, the male-to-female ratio of the offspring,
or pre-weaning-mortality.
DRUG ADMINISTRATION
SERT (Besitran© Pfizer S.A. Madrid, Spain) was administered
orally at a dose of 5.0 mg/kg/day in the animals’ drinking water,
starting on postnatal day 30 (P30) and continuing until the end
of experiments (P90). The SERT solution was prepared using
filtered water as a vehicle. Liquid consumption was controlled
(with calibrated bottles) and monitored every 2 days, and the
dose of the drug was adjusted on the basis of the liquid consump-
tion and animal’s weight. Freshly prepared solutions were then
provided. Filtered water was given to control animals. During
this period, the rats were kept in groups of four animals in
polycarbonate boxes (45 cm× 30 cm× 20 cm), with unrestricted
access to food. A dose of 5 mg/kg/day of SERT was chosen based
on the pharmacokinetic and pharmacodynamic profiles of the
drug (Byerley et al., 1987; West and Weiss, 2005; Matar et al.,
2006), and to minimize the chronic side effects deriving from its
administration (Greenberg et al., 2014). Its elimination half-life
(approximately 26 h) makes administration once a day adequate
(Doogan and Caillard, 1988; Murdoch and McTavish, 1992) and
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oral administration is more akin to clinical reality and provides
adequate and maintained plasma levels (Murdoch and McTavish,
1992).
MEASUREMENT OF THE ACOUSTIC STARTLE RESPONSE
At P30, and again at P90, all animals of both sexes were tested
for the ASR. Before testing, the rats were habituated to the
experimental conditions, especially regarding their introduction
into the ASR apparatus. All testing was carried between 9:00
and 12:00 h, using the SR-LAB system (SDI, San Diego, CA,
USA), as described by Castellano et al. (2009). The acoustic startle
reflexes were measured in six identical startle-response cages
(SR-LAB). Acoustic stimulus intensities and response sensitivities
were calibrated (using an SR-LAB Startle Calibration System)
so that they would be nearly identical in each of the six SR-
LAB systems (maximum variability <1% of stimulus range and
<5% of response ranges). Each testing session consisted of an
acclimatization period of 5 min followed by 64 trials presented
pseudo-randomly, with a mean inter-trial interval of 30 s. Sixteen
of the trials involved a single-noise pulse (115 dB SPL, 20 ms
of burst of white noise, used to determine the ASR), and the
remaining trials consisted of 48 trials of a white noise prepulse at
each of three intensity levels (65, 70, or 80 dB SPL) lasting 20 ms,
followed by the startle stimulus (as above), at 50 ms inter-stimulus
intervals. The session had three blocks of pulse and prepulse, with
prepulse-to-pulse intervals of 50 ms. The first and last blocks
were composed of pulses alone (5 in each block); the second
block comprised 6 pulses alone and 9 of each of the prepulse
intensities, all administered randomly. Whole body movements
corresponding to startling responses were recorded and analyzed
by the SR-LAB system, providing ASR latencies and amplitudes.
The background noise of 65 dB SPL was generated throughout the
entire session in order to avoid interference from external noise
and to ensure equal experimental conditions. The percentage of
habituation was calculated as the reduction in startle magnitude
from block 1 to 3 of five pulses at 115 dB (%HAB = 100 × (first
block – last block)/first block).
OPEN FIELD TEST
Spontaneous behavior was studied with the open-field (OF) test.
The apparatus consisted of a round, white wooden arena (100 cm
diameter, enclosed by a 50-cm-high wall), divided into an inner
(7 areas subdivided into a large and a small center of 6 and 1 areas
respectively) and an outer zone (12 areas adjacent to the wall).
The OF apparatus was illuminated by an 80 W bulb, focused onto
the field from a height of 100 cm above the floor. The behavior of
each animal was studied for a period of 3 min over 3 consecutive
days, and the occurrence of the following types of behavior was
recorded: outer (OA) and inner (IA) exploratory activity (number
of times the animal crossed into each zone and area) and rearings
(Rear) (number of episodes in which the animal reared up on its
back legs).
Between the introductions of each animal, the surfaces were
cleaned with water and 70% ethanol. To minimize subjectivity,
the behavior of the rats was recorded by two experimenters blind
to the treatment conditions. All trials were performed between
11:00 and 14:00 h.
LEUKOCYTE COUNTS AND SUBPOPULATIONS
After the behavioral tests had been completed and after 60 days
of SERT-treatment blood samples were taken between 09:00 and
11:00 h from a subset of animals from each group (n = 6 per group
and sex) by cardiac puncture following intraperitoneal anesthesia
with a mixture of ketamine (200 mg/kg) and xylazine (10 mg/kg).
The blood was immediately transferred to EDTA (K3)-containing
tubes and processed on an automatic cell counter (ADVIA 120
cytometer, Bayer, Leverkusen, Germany).
STATISTICS
The variability within litters for all rats on each experimental
group (given by standard deviations) was similar than the vari-
ability across litters, on all our dependent measures. Also, when
data were analyzed using the effect of litter as a covariate, we
found no significant effects. Thus, in the final analyses the litter as
a variable was not considered and the data from each individual
animal were used.
Statistical analysis were performed using the
IBMr SPSSr software, version 20 (IBM Corp. and SPSS
Inc., Chicago, IL, USA, 2011). The differences between groups
were analyzed by ANOVA (one, two and three way), followed
by the Fisher-PLSD-test for post hoc comparison if appropriate,
and ANOVA mixed (or “SPLIT-PLOT”) with the Bonferroni-test.
Mean differences were subjected pairwise to Student’s t-test, using
the Levene Test for equality of variances. Pearson’s coefficient
was used to determine correlations. Differences were regarded as
statistically significant when p< 0.05.
RESULTS
EFFECTS OF PRENATAL STRESS ON BODY WEIGHT GAIN BEFORE
ADOLESCENCE
As expected, as a main effect of prenatal stress, differences were
observed in the neonates’ body weights the day after delivery
(P1), but only among the female pups (Table 1, F1,30 = 14.04,
p < 0.01), since among the males the body weights of the pups
were similar.
Body weight gain was analyzed using a three-factor ANOVA
(prenatal treatment by sex by age) with repeated measures on the
age factor (at this stage, three levels were used: 1, 21 and 28 days
of age). Analysis of these data revealed that the prenatal treatment
affected body weight gain. As the animals’ age advanced, weight
by treatment (F2,66 = 3.42, p = 0.04) and weight by treatment by
sex (F2,66 = 3.47, p = 0.037) interactions were found, indicating
Table 1 | Animals’ body weight (g) before the beginning of pharmacol-
ogical treatment: at birth (P1), at weaning (P21) and at 4 weeks of
age (P28) (n = 18–20 animals per group and sex).
Females Males
Control Prenatal stress Control Prenatal stress
P1 6.4 ± 1.1 5.9 ± 1.5aa 6.7 ± 1.3 6.2 ± 1.6
P21 40.8 ± 2.4 39.8 ± 2.1 39.5 ± 2.2 43.2 ± 2.7
P28 57.8 ± 2.9 64.8 ± 2.7a 68.2 ± 2.5 66.2 ± 2.8
a p < 0.05 and aa p < 0.01, indicate a main effect of prenatal stress (Fischer LSD
test) (Mean ± standard error).
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differences, in the effect of PS on growth rate, that were sex-
dependent.
Post hoc analysis showed that even though in the males no dif-
ferences were found as an effect of prenatal treatment, but in the
females, these differences were present (F2,30 = 6.24, p = 0.005).
Female pups from stressed mothers had lower birth weights (P1)
than the controls, but these differences disappeared by the time
of weaning (P21). However, this process changed at P28, and
PS females exhibited a higher body weight than their controls
(Table 1, p = 0.03).
At this early stage of development, sex per se, did not influence
weight gain, and no sex differences in the neonates’ body weights
were found at any point.
EFFECTS OF PRENATAL STRESS AND SERTRALINE ON BODY WEIGHT
GAIN FROM ADOLESCENCE TO ADULTHOOD
Pharmacological treatment started once adolescence had begun,
and the animals’ weights were recorded weekly (for statistical
analysis, five levels were used, and mean values were determined
from P35 to P90). During this period, a significant overall effect
of age was observed (F4,73 = 1460, p < 0.001), with group,
F16,304 = 1.69, p = 0.048; sex, F4,73 = 98.8, p < 0.001; and
group by sex, F16,304= 1.81, p = 0.029 interactions affecting body
weight, indicating the influence of the different treatments on
weight gain in each sex. As expected, there was a clear difference
between the growth of males and females throughout adoles-
cence in all experimental groups (weight by sex, F4,73 = 70.8,
p < 0.001), with males weighting more than females (Figure 1).
Accordingly, further analyses were performed separately for each
sex.
At the beginning of this phase (P35) neither the prenatal
manipulation nor the pharmacological treatment affected the ani-
mals’ body weights. However, at P90 (after 2 months of pharma-
cological treatment), differences in body weight (g) were found,
both in females (F3,30 = 4.15, p = 0.014) and males (F3,30 = 1.8,
p = 0.025).
Among the females, there was a main effect of group affecting
weight gain with time, F12,87 = 2.12, p = 0.023. As depicted
in Figure 1A, the animals’ growth was faster in the prenatally
stressed females than in all the other experimental groups, sug-
gesting a long-term effect of the prenatal treatment that was
reversed by SERT-treatment. In fact, SERT treatment affected, at
least marginally, weight gain in the females, but this was only
observed at this age (P90). In males, a major effect of SERT,
affecting body weight gain was observed. After 2 months of
treatment it reached significance among the non-stressed males
(Figure 1B).
Fluid consumption increased with age and was different
between the sexes (final average: 30 ml/day for female and 35
ml/day for male rats), but not between treatments.
ASR MEASURES
The startle response was first examined using a three-way mixed-
design analysis of variance group by sex by age. A significant
increase in startle amplitude was observed from P30 to P90
(F1,77 = 312.3, p < 0.001), with no group interaction, but with
a strong sex interaction (F1,77 = 69.6, p < 0.001), marked by the
differences between sexes seen at P90 (F1,77 = 58.7, p < 0.001),
which were not seen at P30 (Figure 2).
On performing further analyses separately for each sex and
age, no effects of prenatal stress at P30 were observed, whereas
at P90, the greatest difference between groups were found
(F3,77 = 2.67, p = 0.058). Although the difference did not reach
statistical significance by sex, post hoc analysis revealed a marginal
effect of prenatal stress, increasing startle amplitude in rats from
both sexes regardless of SERT treatment. Additionally, SERT
treatment did not induce changes in mean startle amplitude
(Figure 2).
FIGURE 1 | Effects of prenatal stress and SERT treatment (5 mg/kg/day) on body weight gain (g) over time in females (A) and males (B) (n = 9–11
animals per group and sex). a, p < 0.05 indicates a main effect of prenatal stress; b, p < 0.05, indicates a main effect of SERT in Control-SERT vs. Control
(Means ± standard error).
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FIGURE 2 | ASR amplitude (in arbitrary units) at P30 and P90
performed in the animals of both sexes subjected or not to prenatal
stress (PS and CONTROL), vs. subjected or not to prenatal stress and
treated with SERT (Control-SERT and PS-SERT) (5 mg/kg/day). Mean
values ± standard error (at P30, n = 18–20 animals per group and sex; at
P90, n = 9–11 per group and sex). U, p < 0.05 indicates a main effect of sex
in all experimental groups.
On using a block-to-block analysis to study startle ampli-
tude, differences between the different experimental groups were
observed. Startle habituation (difference between the first and the
last block, expressed as percentages) was significantly different
as effect of group, specifically in females (F3,28= 3.3, p = 0.034),
probably given the deterioration of habituation found in PS
females (Figure 3). Startle amplitude remained persistently high
in PS females and was reversed by SERT. Given the different
response to the startle test in the prenatally stressed animals
(F1,69 = 3.5, p = 0.02), sex differences were observed specifically
in PS animals (p = 0.03).
Additionally, there was an overall increase in the latency to
startle from P30 to P90 (F1,77 = 284.9, p< 0.001). Whereas at P30
no differences between groups were found; at P90, the latency to
startle of PS animals was shorter than in the controls (F3,77 =
4.53, p = 0.006). SERT has no effect on this parameter (Figure 4),
and the males showed a higher latency to startle than females
(F1,77 = 23.6, p< 0. 001).
Interestingly, a strong correlation was seen between ASR
amplitude and its latency (r = 0.74, p < 0.001), such that the
animals with higher latency responses were those with greater
startle amplitudes.
OPEN-FIELD ACTIVITY
Neither prenatal stress nor treatment with SERT significantly
changed the activity of the animals in the OF test, although a
strong influence of sex was found.
Upon analyzing the total exploratory activity (total crosses +
rearings) (ANOVA with session by group by gender as within
factors), no group effect was observed, but a major effect of sex
was observed (F1,69 = 11.1, p = 0.002). Females were more active
than males in all the sessions, this difference being significant in
both the Control (+20.59± 9.4, p = 0.034) and PS animals (+26.1
± 9.1, p < 0.01). In the case of the SERT-treated animals, the
differences between sexes lost significance (Control-SERT: +5.9±
9.5, n.s.; PS-SERT: +14.4± 9.8 n.s.).
A comparison of the horizontal and vertical activity performed
in the sessions did not reveal differences due to stress or SERT
treatment in any case (Figures 5A,C, 6A). Again, a major effect of
sex (F1,69 = 10.2, p = 0.02; F1,69 = 3.86, p = 0.05; and F1,69 = 4.7,
p = 0.035, respectively) was observed, given the overall differences
between PS males and females in their willingness to engage in
exploratory activity. PS males exhibited significantly less outer-
field activity (Figure 5A; F1,69 = 4.23, p = 0.045) and inner-field
activity (Figure 5C; F1,69 = 4.24, p = 0.038) and also fewer rearings
than the females from the same group (Figure 6A; F1,69 = 7.47,
p = 0.01).
With the exception of the Control females, in all experi-
mental groups of both sexes the horizontal activity remained
unchanged over the 3 days. In response to repeated expo-
sure to the test, exploration in the OF increased in Con-
trol females (Figures 5B,D; both outer and inner activity).
FIGURE 3 | Effects of prenatal stress and SERT treatment (5 mg/kg/day) on habituation (percentage) in females (A) and males (B) at P90. a, p < 0.05,
indicates a main effect of prenatal stress; U, p < 0.05, indicates a main effect of sex. Means ± standard error.
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FIGURE 4 | Startle latency (stimuli 115 dB) at P30 and P90 in females (A) and males (B). a, p < 0.05 indicates a main effect of prenatal stress in females;
U, p < 0.05, indicates a main effect of sex in all groups except of PS animals (Fischer LSD test). Mean values ± standard error.
FIGURE 5 | Effects of prenatal stress and SERT treatment on the
horizontal activity in the OF test (n = 8–9 per group and sex). Means
± standard error for outer crossing activity (panels A and B) and inner
crossing activity (panels C and D) observed, during 3 min sessions on 3
consecutive days. No differences as effect of prenatal stress or
SERT-treatment were found in outer crossing activity, F3,69 = 2.47; or
inner crossing activity, F3,69 = 0.25. U, p < 0.05 indicates a main effect of
sex on PS animals. *p < 0.05 and ** p < 0.01, indicates a significant
increase on both the number of outer and inner crosses in Control
females.
Furthermore, a different effect of the drug on inner-field activity
was observed for each sex; whereas in females SERT slightly
reduced inner exploration (Figures 5C,D), in males SERT treat-
ment did not affect it, and prenatal stress seemed to be the
only factor that affected such activity, and then only to a slight
extent.
Moreover, the number of rearings also changed significantly
over the 3 days with repeated exposure to the OF (F2,68 = 4.38,
p = 0. 018), with no sex or group interactions (Figure 6B).
As an anxiolytic indicator, the ratio between inner-field
and outer-field activity (IA/OA) was further analyzed, and no
overall differences were found. However, when the analyses
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FIGURE 6 | Effects of prenatal stress and SERT treatment on the
vertical activity in the OF test. Number of rearings observed during 3 min
sessions on 3 consecutive days (Panels A and B). Mean values ± standard
error. No differences as effect of prenatal stress or SERT-treatment were
found, F3,69 = 0.58, p > 0.05. U, p < 0.05 indicates a main effect of sex on
PS animals. * p < 0.05, indicates a significant decrease from day 1 to day 2
of test, on the number of rearings in PS-SERT females.
were split by day and sex, in males, a major effect of group
was noted, specifically on the first day of the test (F3,35 = 2.98,
p = 0.048), indicating an anxiogenic effect of prenatal stress
(Figure 7, p = 0.043). Sex differences were also found in the PS
animals (p = 0.014), indicating that PS increases anxiety in males,
specifically, and that SERT treatment reversed it.
HEMOGRAM: WHITE BLOOD CELL COUNT
The blood leukocyte formula did not vary as a function of sex.
Gestational stress compromised the immune function (Table 2).
FIGURE 7 | Ratio between inner exploratory activity and outer
exploratory activity (IA/OA) on the 1st day of the OF test. a, p < 0.05
indicates a main effect of prenatal stress in males; U, p < 0.05 indicates a
main effect of sex.
Quantitative analysis of the total of the leukocyte count revealed
pronounced leukopenia in previously stressed animals and its
formula was disturbed. In control animals, SERT treatment did
not affect the immune response and in the stressed animals it
returned pre-leukocyte failure values to normal levels. In stressed
animals, differential leukocyte counts (in absolute numbers)
disclosed lymphocyte levels below the normal range.
DISCUSSION
The main findings of the present study highlight the importance
of the exposure during development to environmental challenges
affecting the serotonergic system, these effects persisting into
adulthood. The sex-specific effects of prenatal stress on later
physiological development and anxiety-related behaviors
were remarkable. The impact of prenatal stress on immune
function, later reversed by SERT administration, was observed.
Importantly, it was also noted that, in rats, chronic exposure
to a low dose of SERT (5 mg/kg/day) from adolescence until
adulthood was safe and effective in reversing the harmful effects
of prenatal stress.
Table 2 | Plasma values obtained in the arterial blood in animals of both sexes (at P92).
Group Leukocytes Neutrophils Lymphocytes Monocytes Eosinophils Basophils
(103/µl) (103/µl) (103/µl) (103/µl) (103/µl) (103/µl)
Control 5.45 ± 0.6 0.86 ± 0.1 4.34 ± 0.3 0.09 ± 0.01 0.12 ± 0.01 0.01 ± 0.001
Control-SERT 4.78 ± 0.7 1.16 ± 0.2 3.53 ± 0.6 0.07 ± 0.02 0.12 ± 0.03 0.02 ± 0.003
PS 1.85 ± 0.5aa bb 0.63 ± 0.1 0.93 ± 0.4aa b 0.06 ± 0.01 0.07 ± 0.02 0.003 ± 0.002a
PS-SERT 4.43 ± 0.6 1.00 ± 0.2 3.22 ± 0.6 0.07 ± 0.02 0.09 ± 0.02 0.01 ± 0.003
F = 16.3, p < 0.001 F = 1.9, p = 0.14 F = 18.3, p < 0.001 F = 0.8, p = 0.49 F = 1.6, p = 0.23 F = 7.2, p < 0.01
Means ± standard error (n = 6 per group). a p < 0.05 and aa p < 0.001 indicates a main effect of prenatal stress; b p < 0.05 and bb p < 0.001 indicates a main effect
of SERT.
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BODY WEIGHT GAIN
Perturbations, such as maternal stress, in the uterine environment
during development can permanently alter metabolism and body
weight in the offspring (Pollard, 1984; Jahn et al., 1993; Lordi
et al., 1997; Drago et al., 1999). The latter authors accounted
for this in terms of a decrease in growth hormone (GH) and
androgen production in prenatally stressed animals, which—
having negative influence on growth and food intake—would lead
PS animals to gain less weight.
By contrast, our results indicate that PS females increased
more in weight during growth. Whereas in males no effects
of early stress on weight gain were found, prenatally stressed
females weighed less than their controls at birth. This difference
rapidly disappeared, and was later counteracted, a trend that
persisted into adulthood. Even though, this is in disagreement
with earlier studies addressing prenatal stress in which PS delayed
development (Pollard, 1984; Lordi et al., 1997; Berger et al., 2002),
recently it has been reported in males (Chung et al., 2005; Mueller
and Bale, 2006; Abe et al., 2007) and in both sexes (García-Cáceres
et al., 2010). Many factors may be involved in these differences,
including maternal sensitivity (Mueller and Bale, 2006), the tim-
ing of exposure to stress, or the physical properties of the stressors
employed (Abe et al., 2007).
The rapid weight gain, or “catch-up” growth, reported here
in PS females, that follows low birth weight has already been
described in humans (Cottrell and Ozanne, 2008). According
to Cottrell and Ozanne (2008) the rapid weight gain following
maternal stress has important effects on later health, and so
children born with abnormally low weights have been reported as
being at increased risk of later obesity and related metabolic issues
(Breier et al., 2001; Ozanne and Nicholas Hales, 2005). “Fetal
programming” has been suggested as the origin of this (Breier
et al., 2001; Tabacchi et al., 2007; Cottrell and Ozanne, 2008).
One of the biological causes of disorders involving the loss
of control of the energy balance in humans is dysregulation of
the serotonergic system (Kaye et al., 2005; Marston et al., 2011;
Avena and Bocarsly, 2012). Brain imaging studies in patients with
such disorders have uncovered alterations in 5-HT circuitry (Kaye
et al., 2005; Lam et al., 2010), which have also often been described
in PS animals. Accordingly, it could be speculated that such
changes may at least partly affect the feeding behavior that we
observed in PS females, which was reversed by SERT treatment.
SERT administration also changed weight gain and appetite.
Whereas at the beginning of treatment SERT did not affect food
intake, after 2 months it did. Following SERT treatment the
animals exhibited a loss in body weight in comparison with
their controls. This is in agreement with findings concerning
food seeking behavior reported previously for adult rats, which
describe the effects on weight gain of a variety of drugs able to
increase the synaptic availability of 5-HT (Lucki et al., 1988; de
Magalhães-Nunes et al., 2007; Mandelli et al., 2008). In adolescent
male rats, the group headed by de Jong et al. (2006) also found a
slight effect of another two SSRIs—fluvoxamine and paroxetine—
which reduced growth. As far as we know, the present study is
the first to report the long-term effects of SERT administration
during development in both sexes over such a long study period
(60 days).
A lack of changes in overall liquid intake was found between
the groups; i.e., adding SERT at 5 mg/kg/day to the drinking
water did not seem to influence the search for water. By contrast,
de Magalhães-Nunes et al. (2007) reported that SERT treatment
affected water and sodium intake in rats. However, those authors
used a 20 mg/kg/day dose.
ANXIETY-LIKE BEHAVIOR
According to the literature, the serotonergic system modulates
behavioral states (Dulawa and Geyer, 2000; Siepmann et al.,
2003; Quednow et al., 2004; Iñiguez et al., 2010). However, our
data show that SERT exerted no changes in mean startle reflex
amplitude or in its latency in non-stressed rats.
Prenatal stress in rodents usually results in increased emo-
tionality (Fride et al., 1986; Martí and Armario, 1998). High
ASR amplitudes are found in more emotive animals (Kjær et al.,
2010) and are thus considered good markers of anxiety disorders
(Rasmussen et al., 2008). It is to be expected that the progeny of
stressed mothers would have increased startle responses. However,
the various research groups investigating the effects of PS reported
no, or only marginal, differences in ASR amplitude in prenatally
stressed animals (Lehmann et al., 2000; White and Birkle, 2001;
Koenig et al., 2005). This is in accordance with our results, where
only a slight elevation in startle amplitude was seen as an effect of
prenatal stress in both sexes.
When a block-to-block analysis was performed, differences
were observed. In the present study, PS males, regardless of the
antidepressant treatment, exhibited a marginal elevation in the
acoustically elicited startle reflex over the first few trials in com-
parison with the controls (data not shown). This initial increase
reflects the influence of the novel, potentially aversive stimulus
on the central nervous system, thus indicating PS males as being
more sensitive (Meincke et al., 2004). Also, in rodents, White and
Birkle (2001) reported no differences in mean startle amplitude
values between PS and control progeny, except when response to
novelty was tested.
By contrast, it is expected that with further stimulation, the
controls would interpret the stimuli as being less relevant and
the amplitude course decays in ensuing trials, revealing a pro-
cess of habituation (Martí and Armario, 1998). Our data show
that whereas PS males showed habituation, this was significantly
impaired in PS females, SERT treatment reversing it. Acoustic
startle habituation is a central point in the concept of vulnerability
to stress, because it reveals the extent to which animals are able
to withstand the homeostatic disturbances induced by stress over
time (Koch, 1999; Meincke et al., 2004). The persistence in behav-
ioral responses to repeated stimuli reflects difficulties in adapt-
ing to subsequent stressors and it is seen in psychotic patients
(Meincke et al., 2004), meaning that SERT is an important tool
for reversing stress vulnerability in PS females.
In accordance with our results, other researchers studying the
physiological responses to postnatal stress in rodents found sex
differences, reporting that, when stressed, males showed habitu-
ation while females showed sensitization (Chadda and Devaud,
2005; Buynitsky and Mostofsky, 2009). This sex specificity of
persistently increased ASR in PS females was first reported by
Hougaard et al. (2005).
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Also, the latency to startle was only marginally affected by
prenatal stress. PS animals from both sexes were slightly slower
in becoming startled than their controls, and SERT exerted no
effects. As far as we know this is the first time this effect of prenatal
stress has been reported.
After the animals had been subjected to the OF test, we found
that neither the prenatal stress nor SERT treatment changed
locomotor activity in this test, although there was a marginal
effect of early stress, anxiety increasing specifically in males. A
major effect of sex was found in all parameters measured, females
proving to be more active than males.
In the present work, the OF paradigm was used as a simple
model to study anxiety-like behavior and locomotor activity
(Durand et al., 1999; Prut and Belzung, 2003; Van den Hove et al.,
2005; Rayen et al., 2011). We found sex specificity in susceptibility
to early stress; the PS males exhibited increased anxiety, although
this was hardly significant when compared with the PS females. PS
males showed less exploratory activity and less central exploration
than the females from the same group. SERT reversed it, even
though it did not affect either locomotor behavior or anxiety
significantly in animals from both sexes, in agreement with previ-
ous reviews about this class of antidepressants (Prut and Belzung,
2003).
The sexual dimorphism found in locomotor activity with the
OF test (total crossings + rearings) has already been reported
in rodents (Wakshlak and Weinstock, 1990; Pallarés et al., 2007;
Duchesne et al., 2009), females being always more active than
males in this kind of test. Also, vulnerability to early stress has
been seen previously in the OF test (Wigger and Neumann, 1999;
Nishio et al., 2001; Zueña et al., 2008). According to these authors,
the effects of PS are more pronounced in males, these proving to
be more emotional during the OF test. For instance, Nishio et al.
(2001) reported a decrease in motor activity in neonate PS males,
no effects being observed for PS females.
In the OF test, animals face contradictory motivations—the
fear of an open enlightened environment, and the motivation to
explore it (novelty preference) (Archer, 1973). An internal conflict
underlies the motivation of the animals’ behavior (Fride et al.,
1986), where high emotivity would inhibit exploration and low
emotivity would facilitate it, indicating a better adaptation to the
new environment (Gilad and Shiller, 1989; Durand et al., 1999).
In our study, the control animals were the only ones that increased
their activity with repeated exposure to the OF test.
Nonetheless, the lack of differences caused by PS observed here
is in accordance with previous works (Van den Hove et al., 2005).
Thus, as additional indices of anxiety-like behaviors in the OF
we further determined the animals’ IA/EA activity (Archer, 1973;
Durand et al., 1999; Prut and Belzung, 2003) and found that, only
on the first day, prenatally stressed males exhibited a lower IA/OA
ratio than controls. Again, PS males proved to be more sensitive
to novelty (White and Birkle, 2001).
Additionally, although most authors defend the notion that
SSRIs can normalize anxiety disorders, in rodents they behaved
as anxiogenic, or anxiolytic substances, or even had no effects
when the animals subjected to treatment were tested in behavioral
paradigms (Durand et al., 1999; Prut and Belzung, 2003; Graeff,
2004; de Jong et al., 2006). Many variables can be invoked to
account for the heterogeneity of the results, e.g., the animal
model, sex, the dose or management of the SSRIs and the
inclusion of a rest period. However, the timing of exposure is
a determinant factor. In the present study, we tested the effects
of a low dose of SERT administered during the developmental
period from adolescence to adulthood, anticipating changes in
serotonin-related behavior (Byerley et al., 1987; West and Weiss,
2005; Greenberg et al., 2014).
Adolescence in rodents occurs from postnatal day 28 to day
60 (Spear, 2000) and continues to be an important period of the
development of the nervous system in which the serotoninergic
system is still maturing (de Jong et al., 2006). Being even suggested
the adolescence as a sensitive period (Eiland and Romeo, 2013;
Holder and Blaustein, 2014).
Besides the changes in 5-HT transporters and their receptor
activity, the release of 5-HT from the DRN in adolescent rats is
increased in comparison with adult rats (de Jong et al., 2006) and
the levels of 5-HT in several brain areas are also increased. As a
consequence, the effects of SSRI administration during this period
might be different from those elicited in adults. Actually, de Jong
et al. (2006) reported that giving SSRI to adolescent rats increased
anxiety, and this became apparent when they were tested as adults.
In our work, we found no significant differences in anxiety-related
behaviors between animals receiving SERT as compared with the
controls. However, as expected, SERT played an important role
in mediating the deleterious effects of prenatal stress in both
sexes.
While it is known that SSRIs act mainly by binding to 5-
HT transporters, then blocking 5-HT reuptake and increasing
5-HT availability, it is also known that some SSRIs have other
non-specific neuropharmacological effects (Manji et al., 2001),
partially acting on the inhibition of other neuroactive monoamine
reuptake (Kitaichi et al., 2010) or decreasing corticotropin-
releasing hormone (CRH) neuronal activity (Matar et al., 2006).
More importantly, they modulate glucocorticoid receptors (GRs)
activity in several brain areas (Anacker et al., 2010).
Thus, in addition to the cellular and molecular alter-
ations induced by chronic treatment with SSRIs, reversing
depressive states, other beneficial effects exist. Following the
antidepressant—due increase in 5-HT concentrations in the
median raphe nuclei and hippocampus, the release of neu-
rotrophins (such as BDNF) and hippocampal neurogenesis are
stimulated (Anacker et al., 2010; Willner et al., 2013). These
neuroprotective and neurotrophic effects of 5-HT are known to
block the damaging effects of stress on neurons (Manji et al.,
2001; Morley-Fletcher et al., 2003; Hajszan et al., 2009). In fact, a
role has even been suggested for antidepressants in the structural
plasticity of certain cerebral areas (Pittenger and Duman, 2008).
The effects of antidepressants on the hippocampus seem to be
partly modulated by modifications in other brain areas that also
are the sites of action of SSRIs (Castro et al., 2010). This allows at
least part of the system to be restored to an almost normal state
(Willner et al., 2013).
IMMUNOMODULATORY EFFECT
SERT has been shown to have an immunomodulatory action
once it has reversed the state of leukopenia found in prenatally
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stressed animals. As expected, prenatal stress induced alterations
in the immune function of the offsprings; this could still be
seen when the immune function was determined in adulthood.
A decrease was found in both total leukocyte counts in blood
and in all subpopulation types, lymphocytic cells being those
most affected. This has been extensively described before by
authors proposing that gestational stress compromises immune
function in the offspring (Kay et al., 1998; Coe and Lubach,
2005; Vanbesien-Mailliot et al., 2007; Merlot et al., 2008), with
deleterious effects on leukocyte proliferation (Götz and Stefanski,
2007), and specifically on IgG levels (Sobrian et al., 1992), nat-
ural killer activity (Kay et al., 1998) and immune dysregulation
by promoting pro-inflammatory and type-2 cytokine responses
(Vanbesien-Mailliot et al., 2007). All these authors reported that
prenatal stress altered the immune function of progeny with no,
or only marginal differences, as regards sex, as was observed in the
present study.
The mechanisms underlying the effects of prenatal stress
on the immune system of progeny, probably result from the
action of maternal stress hormones (Barbazanges et al., 1996).
The increased level of glucocorticoids (GCs) reaching the devel-
oping fetus are known to affect the development of the neu-
roendocrine and immune systems (Kay et al., 1998; McEwen,
2008). One consequence is the HPA axis hyperactivity found
in prenatally stressed rat pups that is correlated with high hor-
mone levels, caused by an impaired feedback inhibition of GCs
(glucocorticoid resistance), and these hormonal changes have
been shown to regulate the magnitude and duration of the
immune responses (Sobrian et al., 1992). It is known that GC
binding to GRs induces their activation (transactivation). How-
ever, GRs can instead bind to transcription factors (see Anacker
et al., 2010 for review), resulting in the so-called transrepres-
sion. The typical target genes of GR-mediated transrepression
include inflammatory cytokines, and these latter perform the
immunosuppressive action of GC hormones (Dhabhar, 2007;
Anacker et al., 2010). Given such a dynamic link between
both the immune and neuroendocrine systems, it could be
suggested that prenatally stressed animals exhibit some impair-
ment of the HPA axis, which would affect postnatal immune
function.
Moreover, gestation is an ontogenic period during which some
of the most critical events that allow normal functioning of the
immune system are taking place, and, it is reasonable to assume
that prenatal exposure to environmental protocols might also
cause a temporary or permanent disruption in the genesis or
functioning of the immune system itself (Sobrian et al., 1992).
Many previous studies have shown that a critical immune organ,
the thymus, is extremely sensitive to stress-responsive adrenal
corticosteroids during development (Hougaard et al., 2005). Invo-
lution of the thymus, as well as lytic and apoptotic death of
T cells, occurs even in adults, but is particularly pronounced
in the stressed fetus (Coe and Lubach, 2005; Hougaard et al.,
2005).
The long-term consequences of this early type of stress on
immune function are less well known. Most of these studies
reported effects in neonate or juvenile offspring. Sobrian et al.
(1992) described for the first time that disruption of the immune
system in PS progeny altered the postnatal response of this system
to stress. Here we found that leukocyte count impairment per-
sisted in 90-day old aged animals.
Finally, we demonstrate the central role of SERT in restor-
ing leukocyte levels to normality. The mechanisms underlying
the effects of SSRIs on the immune system under normal and
pathological situations remain to be clarified (Gobin et al., 2014).
Taler et al. (2008) and Gobin et al. (2014) suggested that the
immunomodulatory effect of SSRIs would be related to their pro-
apoptotic activity, and to their action on lymphocyte prolifera-
tion and to cytokine secretion. This may have been the case in
our work as a consequence of normalizing the altered neuroen-
docrine function in prenatally stressed animals. Moreover, it is
known that SSRIs improve 5-HT levels and can act directly on
hippocampal cells, changing GR binding and regulating GRm-
RNA expression in neuronal cells (Smythe et al., 1994; Anacker
et al., 2010).
As far as we know this is the first work to study the impact of
SERT in reversing the adverse effects of prenatal stress on immune
competence. The low doses used here may have been crucial,
since Sacre et al. (2010), for instance, reported that a low dose
of another SSRI (fluoxetine) was needed to produce significant
changes in autoimmune disease and cancer.
In conclusion, our results contribute to the general knowledge
about the beneficial effects of SERT, a drug known to exert anti-
depressive effects, reversing early stress-associated impairments.
Such beneficial effects are therefore of considerable interest in
clinical practice. Also, the central role of sex susceptibility to
maternal restriction stress is highlighted. The sex-dependent
effects reported here could be due to the sex-specific timing of
developmental processes during gestation (Roussel et al., 2005).
This should be addressed in future studies.
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